HYDROCODONE BITARTRATE AND ASPIRIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hydrocodone Bitartrate And Aspirin, and when can generic versions of Hydrocodone Bitartrate And Aspirin launch?
Hydrocodone Bitartrate And Aspirin is a drug marketed by Lgm Pharma and is included in one NDA.
The generic ingredient in HYDROCODONE BITARTRATE AND ASPIRIN is aspirin; hydrocodone bitartrate. There are twenty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aspirin; hydrocodone bitartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDROCODONE BITARTRATE AND ASPIRIN?
- What are the global sales for HYDROCODONE BITARTRATE AND ASPIRIN?
- What is Average Wholesale Price for HYDROCODONE BITARTRATE AND ASPIRIN?
Summary for HYDROCODONE BITARTRATE AND ASPIRIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| DailyMed Link: | HYDROCODONE BITARTRATE AND ASPIRIN at DailyMed |
Pharmacology for HYDROCODONE BITARTRATE AND ASPIRIN
| Drug Class | Nonsteroidal Anti-inflammatory Drug Opioid Agonist Platelet Aggregation Inhibitor |
| Mechanism of Action | Cyclooxygenase Inhibitors Opioid Agonists |
| Physiological Effect | Decreased Platelet Aggregation Decreased Prostaglandin Production |
US Patents and Regulatory Information for HYDROCODONE BITARTRATE AND ASPIRIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lgm Pharma | HYDROCODONE BITARTRATE AND ASPIRIN | aspirin; hydrocodone bitartrate | TABLET;ORAL | 205479-001 | May 28, 2021 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
